DSL
DoubleLine Income Solutions Fund
$10.94
+2.15%
$1.1B
No data for this timeframe.
Vol
Market Cap$1.1B
Cap SizeSmall Cap
Inst. Holders3 funds
Inst. Value$62.3M
Inst. Activity1 buys / 0 sells
Recent Activity
Inst.
WELLS FARGO & COMPANY/MN — ADD
2,352,914 shares ($26.5M)
Inst.
CITADEL ADVISORS LLC — NEAR_EXIT
14,023 shares ($176.8K)
Analyst Ratings
0Strong Buy
0Buy
3Hold
4Sell
1Strong Sell
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| MORGAN STANLEY | $30.6M | — |
| WELLS FARGO & COMPANY/MN | $26.5M | ADD |
| BANK OF AMERICA CORP | $5.1M | — |
3 institutional holders with $62.3M total value (5,525,170 shares) as of 2025-Q4. Top holders: MORGAN, WELLS, BANK. Net buying activity: 1 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | MORGAN STANLEY | 2,718,268 | $30.6M | 49.2% | — |
| 2 | WELLS FARGO & COMPANY/MN | 2,352,914 | $26.5M | 42.6% | ADD +68.3% |
| 3 | BANK OF AMERICA CORP /DE/ | 453,988 | $5.1M | 8.2% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| WELLS FARGO & COMPANY/MN | ADD | 1,397,904 | 2,352,914 | +68.3% | $26.5M | 2025-Q4 |
| CITADEL ADVISORS LLC | NEAR_EXIT | 255,633 | 14,023 | -94.5% | $176.8K | 2025-Q1 |
| CITADEL ADVISORS LLC | DOUBLED | 19,255 | 255,633 | +1227.6% | $3.2M | 2024-Q4 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 0% buy across 8 analysts — 0 strong buy, 0 buy, 3 hold, 4 sell, 1 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Mar 1, 2025 | 0 | 0 | 3 | 4 | 1 | 0% | |
| Feb 1, 2025 | 0 | 0 | 3 | 4 | 1 | 0% | |
| Jan 1, 2025 | 0 | 0 | 3 | 4 | 1 | 0% | |
| Dec 1, 2024 | 0 | 0 | 3 | 4 | 1 | 0% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.